Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.
Peptide A
Sleep
Endogenous nonapeptide that promotes delta wave sleep and modulates neuroendocrine stress responses.
Peptide B
Cognitive
Russian-approved anxiolytic peptide derived from tuftsin with nootropic and immunomodulatory properties.
Typical vial
5 mg
Typical dose
100-300 mcg
Half-life
~7-8 minutes (rapidly degraded by aminopeptidases)
FDA status
Not FDA approved for human use. No clinical trials submitted…
Typical vial
5 mg
Typical dose
250-500 mcg
Half-life
~15-30 minutes (extended biological effect due to downstream signaling)
FDA status
Not FDA approved for human use.
DSIP effects
Selank effects
DSIP side effects
Selank side effects
DSIP dosing ranges
Sleep support
100-300 mcg · Once daily, 30-60 minutes before bedtime (SubQ) · 2-4 weeks
Stress and cortisol modulation
100-200 mcg · Once daily (SubQ) · 2-4 weeks
Selank dosing ranges
Anxiolytic and cognitive enhancement (intranasal)
250-500 mcg · Two to three times daily · 2-4 weeks
Subcutaneous injection
250-500 mcg · Once daily · 2-4 weeks
DSIP: Endogenous nonapeptide that promotes delta wave sleep and modulates neuroendocrine stress responses. Typical dose 100-300 mcg. Selank: Russian-approved anxiolytic peptide derived from tuftsin with nootropic and immunomodulatory properties. Typical dose 250-500 mcg. Both fall under the Sleep and Cognitive categories.
Stacking DSIP with Selank is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.
DSIP is typically dosed: Once daily, 30-60 minutes before bedtime (SubQ) for Sleep support; Once daily (SubQ) for Stress and cortisol modulation. Selank is typically dosed: Two to three times daily for Anxiolytic and cognitive enhancement (intranasal); Once daily for Subcutaneous injection.
DSIP: Not FDA approved for human use. No clinical trials submitted for FDA review. Selank: Not FDA approved for human use.
Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.
Get Started Free